Diagnostic utility of brain-natriuretic peptide for left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients

Diabetes, Obesity and Metabolism

Volumn 9, Issue 3, 2007, Pages 323-329

  Shimabukuro, M ^a   Higa, N ^a   Oshiro, Y ^a   Asahi, T ^a   Takasu, N ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Brain natriuretic peptide; Diastolic dysfunction; Echocardiography; Receiver operating characteristic

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VOLUME; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIASTOLIC DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE VOLUME; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE;

EID: 33947676360     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00607.x     Document Type: Article

References (21)

1. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202.
2. Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: A prospective community-based study. Am J Med 1999; 106: 605-612.
3. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: An update. Diabetes Care 2004; 27: 1879-1884.
4. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 1992; 117: 502-510.
5. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-1674.
6. Fisher M, Baessler A, Hense HW et al. Prevalence of left ventricular diastolic dysfunction in the community Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24: 320-328.
7. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865-875.
8. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001; 24: 5-10.
9. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
10. Krishnaswamy P, Lubien E, Clopton P, Koon J. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001; 111: 274.
11. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
12. Rakowski H, Appleton C, Chan KL et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: From the Investigators of Consensus on diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 1996; 9: 736-760.
13. Moller JE, Sondergaard E, Seward JB, Appleton CP, Egstrup K. Ratio of left ventricular peak E-wave velocity to flow propagation velocity assessed by color M-mode Doppler echocardiography in first myocardial infarction: Prognostic and clinical implications. J Am Coll Cardiol 2000; 35: 363-370.
14. Shub C, Klein AL, Zachariah PK, Bailey KR, Tajik AJ. Determination of left ventricular mass by echocardiograph in a normal population: Effect of age and sex in addition to body size. Mayo Clin Proc 1994; 69: 205-211.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Clerico A, Del Ry S, Giannessi D. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: The need for a new generation of immunoassay methods. Clin Chem 2000; 46: 1529.
17. Hanley JA, McNeil BJ. The meaning and use of the area under receiving operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
18. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991; 44: 763-770.
19. Valle R, Bagolin E, Canali C et al. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur J Echocardiogr 2006; 7: 40-44.
20. Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, Marwick TH. Screening for heart disease in diabetic subjects. Am Heart J 2005; 149: 349-354.
21. Ren J, Ceylan-Isik AF. Diabetic cardiomyopathy: Do women differ from men? Endocrine 2004; 25: 73-83.